Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.
Lucas Augusto Moysés FrancoCarlos H V MoreiraLewis F BussLea C OliveiraRoberta C R MartinsErika R ManuliJosé A L LindosoMichael P BuschAlexandre C PereiraEster C SabinoPublished in: International journal of molecular sciences (2021)
These data suggest that part of adverse BZN reactions might be genetically determined and may facilitate patient risk stratification prior to starting BZN treatment.